Natco Pharma informs about press release

02 Jul 2018 Evaluate

Natco Pharma has informed about press release titled, 'NATCO launches fixed dose combination of Sofosbuvir-Daclatasvir drug for Hepatitis C treatment in INDIA'.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

961.65 4.15 (0.43%)
19-Mar-2026 10:38 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1765.50
Dr. Reddys Lab 1279.25
Cipla 1261.70
Zydus Lifesciences 886.00
Lupin 2285.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×